| Value | ₹87.75 Cr |
|---|
BSE filing, BSE: 543920. Summary written from the filing by ALFA Finder's alert engine.
CFF Fluid Control Ltd: key numbers
- Share price
- ₹918.20
- Market cap
- ₹1,788 Cr
- Revenue (annual)
- ₹208.7 Cr
- Net profit (annual)
- ₹39.20 Cr
- Promoter holding
- 68.10%
- FII holding
- 0.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CFF Fluid Control Ltd
All →CFF Fluid Control Other Announcement
This filing provides the quarterly shareholding pattern for CFF Fluid Control Ltd as of September 30, 2026. It is a mandatory periodic regulatory compliance disclosure.
CFF Fluid Control Other Announcement
Director Sunil Menon acquired 3,000 equity shares of CFF Fluid Control Ltd through a market purchase. The transaction, valued at ₹0.34 Crore, was executed on the BSE.
- Value
- ₹0.34 Cr
CFF Fluid Control Other Announcement
Director Sunil Menon purchased 1,050 equity shares of CFF Fluid Control Ltd via a market transaction worth ₹0.12 Crore.
- Value
- ₹0.12 Cr
CFF Fluid Control Other Announcement
Director Sunil Menon purchased 1,051 shares of CFF Fluid Control Ltd via market acquisition, valued at ₹0.11 Crore.
- Value
- ₹0.11 Cr
CFF Fluid Control Other Announcement
Director Sunil Menon purchased 3,299 CFF Fluid Control shares on BSE for ₹0.32 Crore. This is a routine PIT Reg 7(2) insider-trading compliance disclosure.
- Value
- ₹0.32 Cr
CFF Fluid Control SME to Main Board Migration
CFF Fluid Control Limited received approval from the BSE to migrate its equity shares from the BSE SME platform to the BSE Mainboard.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr